Evidence map›Paper›PMID 37388273›Full record

ArticleOrganometallics2023

Expanding the Utility of β-Diketiminate Ligands in Heavy Group VI Chemistry of Molybdenum and Tungsten.

Daniel Leitner, Benjamin Wittwer, Florian R Neururer, Michael Seidl, Klaus Wurst, Frank Tambornino, Stephan Hohloch

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Organometallics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel LeitnerFaculty of Chemistry and Pharmacy, Institute for General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, Innsbruck 6020 Austria.
Benjamin WittwerFaculty of Chemistry and Pharmacy, Institute for General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, Innsbruck 6020 Austria.
Florian R NeururerFaculty of Chemistry and Pharmacy, Institute for General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, Innsbruck 6020 Austria.
Michael SeidlFaculty of Chemistry and Pharmacy, Institute for General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, Innsbruck 6020 Austria.
Klaus WurstFaculty of Chemistry and Pharmacy, Institute for General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, Innsbruck 6020 Austria.
Frank TamborninoFachbereich Chemie and Wissenschaftlichen Zentrum für Materialwissenschaften (WZMW), Phillips-University Marburg, Hans-Meerwein-Straße 4, 35043 Marburg, Germany.ORCID https://orcid.org/0000-0003-3538-6049
Stephan HohlochFaculty of Chemistry and Pharmacy, Institute for General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, Innsbruck 6020 Austria.ORCID https://orcid.org/0000-0002-5353-0801

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the synthesis of 17 molybdenum and tungsten complexes supported by the ubiquitous BDI ligand framework (BDI = β-diketiminate). The focal entry point is the synthesis of four molybdenum and tungsten(V) BDI complexes of the general formula [MO(BDI

Identifiers

PMID37388273
PMCPMC10302891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.